Posters

Visual outcome after cataract surgery with an enhanced intermediate vision monofocal intraocular lens in patients with concomitant ocular diseases

Poster Details

First Author: N.Kitnarong THAILAND

Co Author(s):                        

Abstract Details

Purpose:

To evaluate the visual outcome after cataract surgery with a new monofocal intraocular lens (IOLs), enhanced for intermediate vision in patients with concomitant ocular diseases

Setting:

A retrospective, non-comparative study

Methods:

This was a retrospective review of patients with cataract and concomitant ocular diseases who underwent uneventful cataract surgery with an enhanced intermediate vision monofocal IOLs implantation (Tecnis Eyhance ICB00; Johnson & Johnson Vision Care, Inc.) at the faculty of Medicine Siriraj hospital, Mahidol university, Bangkok, Thailand during September 2019 to February 2020. The data collection included demographic data, pre and post-operative distant best-corrected visual acuity (logMAR) (BCVA), intraocular pressure (IOP), post-operative intermediate visual acuity at 66 cm. (logMAR)(IVA) and refraction (spherical equivalence; SE).

Results:

A total of 25 eyes of 19 patients with the mean age of 67.8 year-olds were evaluated in this study. The concomitant ocular diseases included 8 primary open angle glaucoma, 9 primary angle-closure glaucoma, 2 pathologic myopia, 1 nanophthalmos, 1 chronic anterior uveitis with secondary glaucoma, 1 pigment dispersion syndrome, 1 neovascular glaucoma and 2 visual field defect from ischemic stroke. The BCVA improved significantly from 0.33 preoperatively to 0.12 postoperatively (p=0.03). The mean postoperative IVA was 0.42. In patients with glaucoma, the mean postoperative IOP (13.47 mmHg) was not significantly different from preoperative IOP (13.95 mmHg) (p=0.36). Mean postoperative SE was -0.31 diopters. There was no reported photic phenomenon after the surgery.

Conclusions:

In cataract patients with concomitant ocular diseases, the enhanced intermediate vision monofocal IOLs (Eyhance ICB00) provided intermediate vision without the impairment of the distant BCVA or photic phenomenon.

Financial Disclosure:

research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented